Introduction {#s1}
============

Molecular chaperones typically prevent the aggregation and assist with the folding of non-native proteins ([@bib3]; [@bib7]). Thus, chaperones are central to protein homeostasis in the cell and are essential for life ([@bib18]; [@bib39]). Recent studies have also highlighted molecular chaperones as inhibitors of amyloid formation ([@bib29]; [@bib49]). Despite major advances in the field, how chaperones engage and alter the folding properties of non-native proteins remain poorly understood ([@bib17]; [@bib22]; [@bib26]; [@bib27]; [@bib41]; [@bib45]; [@bib46]; [@bib54]; [@bib56]). Despite common features, the mechanisms of activity are distinct in different families of chaperones ([@bib32]). Studies of ATP-dependent chaperones, such as the Hsp70 and GroEL systems, have shown how cycles of ATP binding, hydrolysis and nucleotide release can give rise to different conformational states that exhibit distinct affinities for the substrate protein ([@bib2]; [@bib9]; [@bib16]; [@bib25]; [@bib33]; [@bib44]; [@bib46]; [@bib57]). Much less is known about how ATP-independent chaperones assist with protein folding ([@bib48]).

The trigger factor (TF) chaperone has several unique features ([@bib20]; [@bib40]; [@bib55]): (i) is the only ribosome-associated chaperone in bacteria; (ii) with an estimated cellular concentration of \~50 μM ([@bib10]) it is also the most abundant one; (iii) in contrast to other oligomeric chaperones such as GroEL, SecB, and Hsp90 that form stable oligomers, TF undergoes a dynamic transition between a monomeric and a dimeric form; (iv) TF functions both at the ribosome and in the cytosol: it binds, as a monomer, next to the exit channel at the ribosome to prevent the aggregation and premature folding of nascent polypeptides, while it functions as a dimer in the cytosol where is thought to assist in various processes in protein folding and biogenesis ([@bib1]; [@bib13]; [@bib15]; [@bib31]; [@bib37]; [@bib52]). TF is also being widely used as a co-expression factor to improve the folding and yield of soluble proteins in biotechnology ([@bib53]).

We recently determined the atomic resolution structure of TF in complex with a non-native protein ([@bib45]). The structure revealed how the chaperone recognizes and engages the non-native protein and how it retains it in an unfolded state. Interestingly, our data showed that substrate protein binding causes TF to monomerize, thus indicating that the substrate-binding sites are occluded in dimeric TF. The interplay between substrate protein binding and chaperone oligomerization is likely to be used as a mechanism to modulate the energetics and kinetics of interaction in chaperone-substrate protein complexes, as for example in small heat shock proteins ([@bib12]). The large size of the dimeric TF (100 kDa) and its apparent dynamic nature has hindered determination of its structure.

We have taken advantage of recent advances in NMR spectroscopy and isotope labeling ([@bib21]) to determine the atomic structure of dimeric TF. The structure shows that three out of the five substrate-binding sites are partially buried in the dimer, thus explaining why protein binding results in TF monomerization. Interestingly, the dimer assembles in such a way that substrate-binding sites in the two subunits form a large contiguous surface inside a cavity. The structural data explain the unexpected finding that non-native proteins appear to bind with higher association rate to the dimeric TF than to the monomeric TF. Activity assays showed that TF dimerization enables the chaperone to exhibit stronger holdase and anti-aggregation activity.

Results {#s2}
=======

Characterization of TF dimerization {#s2-1}
-----------------------------------

*Escherichia coli* TF consists of 432 amino acids, comprising RBD (residues 1 to 112), PPD (residues 150 to 246), and SBD (residues 113 to 149 and 247 to 432) ([Figure 1A](#fig1){ref-type="fig"}). Both multi-angle light scattering (MALS) and NMR studies show that TF forms

![Dimerization of TF in solution.\
(**A**) Structure of *E. coli* TF (PDB code: 1W26). PPD, SBD, and RBD are shown in green, pink, and blue, respectively. The residue boundaries for each one of the three domains are shown in parentheses. SBD is discontinuous and is formed primarily by the C-terminal domain. (**B**) Size exclusion chromatography (SEC)-MALS of unliganded TF shows that the protein forms a dimer (Theoretical molar mass: 96 kDa) in solution.](elife-35731-fig1){#fig1}

a dimer of \~ 100 kDa in solution ([Figure 1B](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). MALS and analytical ultracentrifugation (AUC) experiments yielded a dimerization dissociation constant (*K*~d~) of \~ 2 μM ([Figure 1---figure supplement 1B--D](#fig1s1){ref-type="fig"}), which is similar to previously reported values ([@bib24]; [@bib28]; [@bib35]). TF monomerization induced by substrate binding was previously reported ([@bib45]) and has been further corroborated in the present work by MALS and NMR ([Figure 1---figure supplement 1A,E and F](#fig1s1){ref-type="fig"}). The intrinsic dissociation rate (*k~diss~*) of the dimer was measured by tryptophan fluorescence following rapid dilution of TF ([Figure 1---figure supplement 1G](#fig1s1){ref-type="fig"}). Fitting of the data to a single exponential function resulted in *k~diss~* of \~10 s^−1^, which indicates that the dimer is quite dynamic and thus the exchange between formation and dissociation of the dimer can be a major cause of the line broadening observed for the resonances located in RBD ([@bib35]) ([@bib45]). This is further supported by the observation that line broadening at the interface of dimeric TF is suppressed in concentrated TF samples (\~1 mM; [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). Previous studies employing fluorescent labeling ([@bib24]) or (1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-ethanethiosulfonate (MTSL) spin labeling tags ([@bib35]) reported slower dissociation rates, likely due to the strong hydrophobic nature of the tag.

Structure of dimeric TF. We used NMR spectroscopy to determine the structure of the 100 kDa dimeric form of TF in solution (see Materials and methods). We used U-^12^C,^15^N-labelled TF samples that contained specifically protonated methyl groups of Ala, Val, Leu, Met, Thr and Ile (δ1) and protonated aromatic residues Phe, and Tyr in an otherwise deuterated background ([@bib21]; [@bib51]) ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). The high sensitivity and resolution of the methyl region, combined with the high abundance of these eight amino acids in TF ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) and in the dimeric TF interface provided a large number of intra- and inter-molecular nuclear Overhauser effects (NOEs) ([Table 1](#table1){ref-type="table"}).
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###### Structural and NMR statistics of TF dimer.

  Distance restraints\*                          
  ---------------------------------------------- ---------------
  NOEs                                           
     Short range (intraresidue and sequential)   870
     Medium range (2 \< \| i-j \| \< 5)          467
     Long range ( \| i-j \| \> 5 )               1230
     Intermolecular                              54
  Hydrogen bonds                                 374
  Dihedral angle restraints (cp and              1358
  Violations (mean and SD)\*                     
     Distance restraints (A)                     0.005 ± 0.025
     Dihedral angle restraints (°)               0.02 ±
  0.23                                           
  Structural coordinates rmsd\*                  
     RBD core (1-39, 51-112)                     
      Chain A                                    
       Backbone atoms                            1.50 ± 0. A
       All heavy atoms                           2.04 ± 0.29 A
      Chain B                                    
       Backbone atoms                            1.56 ± 0.41 A
       All heavy atoms                           2.07 ± 0.38 A
     PPD core (157-190,195-241)                  
      Chain A                                    
       Backbone atoms                            0.87 ± 0.09 A
       All heavy atoms                           1.38 ± 0.07 A
      Chain B                                    
       Backbone atoms                            0.82 ± 0.14 A
       All heavy atoms                           1.30 ± 0.11 A
     SBD core (115-149, 250-321, 329-428)        
      Chain A                                    
       Backbone atoms                            1.40 ± 0.21A
       All heavy atoms                           2.17 ± 0.23 A
      Chain B                                    
       Backbone atoms                            1.34 ± 0.16A
       All heavy atoms                           2.14 ± 0.20 A
  Ramachandran plot\*                            
     Most-favored regions                        85.4%
     Additionally allowed regions                14.3%
     Generously allowed regions                  0.3%
     Disallowed regions                          0.0%

\*The statistics apply to the 20 lowest-energy structures.

The structure of dimeric TF is shown in [Figure 2](#fig2){ref-type="fig"}. TF forms a symmetric dimer in a head-to-tail orientation. Part of RBD inserts into a large cavity that is formed between the SBD and PPD of the other subunit ([Figure 2A and B](#fig2){ref-type="fig"}) and the arrangement results in three major interfaces that hold the dimer together ([Figure 2C](#fig2){ref-type="fig"}). The three helices in RBD (α1-α3) form extensive contacts with PPD and the SBD arm 1 and arm 2 regions. Specifically, a hydrophobic patch in SBD arm 1 consisting of bulky hydrophobic residues (Leu314, Phe322, Leu332, Leu336, and Phe337) forms intimate nonpolar contacts with the C-terminal region of RBD helix α1 (Val35, Ala36, Val39, and Ile41) ([Figure 2C](#fig2){ref-type="fig"}). This binding interface is further strengthened by a salt bridge between Arg40 and Glu339 and a hydrogen bond between Lys38 and Gln340. SBD arm 1 also interacts with the N-terminal part of RBD helix α3 exclusively via polar contacts (e.g. between Asp65 and Arg321) ([Figure 2C](#fig2){ref-type="fig"}). 2,540 Å^2^ (1,620 Å^2^ nonpolar and 920 Å^2^ polar) of surface are buried in this interface of the dimer. A large hydrophobic patch in PPD consisting of aromatic and bulky nonpolar residues (Phe168, Phe185, Met194, Ile195, Tyr221) engages the long loop in RBD connecting helices α1 and α3, which also features a short helix (α2). Residues Phe44, Val49, Ile53, and Tyr58 in RBD appear to establish the most important contacts with PPD, including two salt bridges (between Arg57 and Asp184 and between Lys48 and Glu199) ([Figure 2C](#fig2){ref-type="fig"}). 2,650 Å^2^ (1,900 Å^2^ nonpolar and 750 Å^2^ polar) of surface are buried in this interface. The third major dimeric interface is mediated by SBD arm 2 and the C-terminal region of RBD helix α3. Similar to the other two, this interface is made up primarily of nonpolar residues (RBD residues Ile76, Ile79, Ile80 and Ile84; SBD residues Val384, Tyr388, Phe387, and Leu394) with additional salt bridges at the periphery of the binding site. 1,480 Å^2^ (1,050 Å^2^ nonpolar and 430 Å^2^ polar) are buried at this dimeric interface, which is the smallest among the three ones. A total surface of 6,670 Å^2^ is buried upon dimer formation. The extensive interface seen in the structure to mediate the dimer was tested by mutagenesis and a triple amino-acid substitution variant (V39E/I76E/I80A; hereafter TF^mon^) was identified that abolishes TF dimerization ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). A recently reported low-resolution structural model of TF dimer also showed a head-to-tail orientation of the two subunits ([@bib35]). However, the dimeric interface is very different from the one observed in our structure ([Figure 2---figure supplement 3](#fig2s3){ref-type="fig"}).

![Structural basis for TF dimerization.\
(**A**) The lowest-energy structure of the TF dimer is shown as space-filling model. TF forms a dimer in a head-to-tail orientation. RBD, SBD, and PPD are shown in blue, magenta, and green, respectively. (**B**) One of the TF subunits is shown as space-filling model and the other subunit shown in ribbon. The helices of the RBD and the two arm regions are labeled. (**C**) Expanded views of the dimeric interfaces highlighting contacts between the two subunits. Residues involved in mediating dimerization are shown as ball-and-stick.](elife-35731-fig2){#fig2}

Superposition of the crystallographically determined structure of the monomeric TF ([@bib13]) on one of the subunits of the dimeric TF demonstrates that TF undergoes major conformational changes as it transitions from the monomeric to the dimeric state ([Figure 3A](#fig3){ref-type="fig"}). With respect to SBD, RBD undergoes a 60° rotation and a 21 Å translation, whereas PPD undergoes a 74° rotation and a 19 Å translation. As a result, PPD moves closer to SBD within the same subunit, and the two domains form a large cavity wherein the RBD of the other subunit inserts into ([Figures 2](#fig2){ref-type="fig"} and [3A](#fig3){ref-type="fig"}). These conformational changes results in a more compact TF structure in the dimeric form, which is consistent with small-angle X-ray scattering (SAXS) data ([@bib40]).

![Conformational changes of TF upon dimerization.\
(**A**) The structure of one subunit in the TF dimer (colored as in [Figure 1A](#fig1){ref-type="fig"}) and the crystal structure of monomeric TF (colored grey) \[Protein Data Bank (PDB) code: 1W26\] are superimposed for SBD. The changes in rotation and translation of the RBD and PPD between the monomer and the dimer are indicated. (**B**) View of the structure of dimeric TF highlighting the positioning of the substrate-binding sites (colored orange). The five main substrate-binding sites are labeled A, B, C, D, and E.](elife-35731-fig3){#fig3}

Dimerization buries the ribosome- and substrate-binding sites. The structural data suggest that TF dimerization has profound impact on the function of TF because the ribosome-binding region as well as several of the substrate-binding sites are buried in the dimer ([Figure 3B](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). The RBD loop, which contains the signature motif (G^43^FRxGxxP^50^) mediating the interaction of TF with the ribosome, is sequestered by the PPD of the other subunit in the TF dimer and thus is not available for binding to the ribosome. This finding explains why TF must monomerize upon binding to the ribosome ([@bib13]). The intrinsic affinity of TF for the ribosome ([@bib24]; [@bib28]) (*K*~d~ \~0.5 μM; [Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}) is comparable to the dimerization *K*~d~ (\~2 μM); therefore, there is a strong competition between TF dimerization and ribosome binding. Because the affinity of TF for ribosome-nascent-chain (RNC) complexes is substantially stronger (*K*~d~ \<0.01 μM) ([@bib5]; [@bib43]) than for vacant ribosomes, translating ribosomes will be invariably bound, and thus protected by TF.

TF uses five distinct binding sites ([Figure 3B](#fig3){ref-type="fig"}) to interact with unfolded substrates such as the maltose binding protein (MBP) ([@bib45]). Four of these substrate-binding sites are located in SBD (A-D) and the fifth one (E) is located in PPD. In the dimeric form of TF only two (A and D) among these five substrate-binding sites are fully accessible for binding, whereas the other three (B, C, and E) are partially occluded ([Figure 3B](#fig3){ref-type="fig"}). A protein substrate typically engages at least four of the binding sites ([@bib45]); thus, complex formation between TF and an unfolded protein requires that TF monomerize, as supported by NMR and MALS data ([Figure 1---figure supplement 1A,E and F](#fig1s1){ref-type="fig"}) ([@bib45]). Previous crystallographic data indicated that TF may also bind to small folded proteins as a dimer ([@bib30]). However, NMR characterization of such complexes in solution showed that the substrates are in an unfolded state and TF is in the monomeric state ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}).

Dimerization modulates the chaperone activities of TF. The concentration of TF in the cell (\~50 μM) is 2 to 3-fold that of the ribosome ([@bib38]), and given the low *K*~d~ of dimerization (\~2 μM) the vast majority of free TF in the cytoplasm will exist in the dimeric form. The dissociation rate (*k*~diss~) of the dimer is \~ 10 s^−1^ indicating a rather dynamic TF dimer with a residence time of \~ 100 ms ([Figure 1---figure supplement 1G](#fig1s1){ref-type="fig"}). We sought to investigate whether the chaperone activity of TF is affected as it transitions between the monomeric and dimeric forms. To characterize the chaperone activity of the monomeric form of TF, we used the TF^mon^ variant ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). The amino acid substitutions that abolish dimerization in this variant are located in RBD and thus do not affect protein substrate binding. First, we performed aggregation assay using the 35 kDa protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the absence and presence of TF or TF^mon^. Denatured GAPDH was diluted into buffer and its aggregation was monitored by light scattering. The results showed that dimeric TF was substantially more efficient at suppressing aggregation than the monomeric TF ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1](#fig4s1){ref-type="fig"}). Interestingly, decreased anti-aggregation activity of another monomeric variant, TF^ΔRBD^ ([Figure 2---figure supplement 2E](#fig2s2){ref-type="fig"}), has also been reported previously ([@bib34]). Note that the results for TF^ΔRBD^ and TF monomeric mutant are essentially identical in our GAPDH aggregation and MBP refolding assays. The anti-aggregation assay was also performed using a shorter substrate protein OmpA^1-192^ ([Figure 4B](#fig4){ref-type="fig"}). The results showed that in the case of shorter substrate, which has a smaller number of hydrophobic regions ([Figure 4---figure supplement 2](#fig4s2){ref-type="fig"}), the difference in the anti-aggregation activity between the dimeric TF and monomeric TF is much less pronounced and both species are equally efficient in suppressing aggregation.

![Effect of TF dimerization on chaperone activities.\
Aggregation of GAPDH in the absence or presence of TF and TF^mon^ at 0.5 μM (**A**) and OmpA in the absence or presence of TF and TF^mon^ at 4 μM (**B**). (**C**) Refolding of MBP in the absence or presence of TF and TF^mon^. The solid line represents the fit of the data to a single exponential function. (**D**) Folding rates of MBP from the analysis of the curves shown in panel C. (**E**) Refolding of the slowly-folding MBPY283D variant in the absence or presence of TF and TF^mon^.](elife-35731-fig4){#fig4}

Next, we examined the efficiency of TF in assisting with the folding of MBP. Denatured MBP was diluted into buffer and its refolding was monitored by the characteristic increase in tryptophan fluorescence intensity in the absence and presence of TF or TF^mon^ ([Figure 4C](#fig4){ref-type="fig"}) ([@bib2]; [@bib8]). At 1:1 stoichiometric ratio with MBP, TF^mon^ had a minimal effect on MBP folding whereas dimeric TF had a pronounced effect ([Figure 4C](#fig4){ref-type="fig"}). Specifically, dimeric TF increased the apparent folding rate of MBP and at the same time increased the yield of the soluble fraction substantially ([Figure 4C and D](#fig4){ref-type="fig"}). The increase in the apparent folding rate is likely due to the most efficient suppression of aggregation by the dimeric TF ([@bib2]). Notably, a much higher TF^mon^ concentration was needed to match the chaperone activity of the dimeric TF ([Figure 4C and D](#fig4){ref-type="fig"}). We also tested the effect of TF on an aggregation-prone, slowly folding mutant of MBP (MBP^Y283D^) ([@bib22]; [@bib45]). The dimeric TF was observed to have a strong 'holdase' effect on the mutant MBP as evidenced by the suppression of the folding of MBP^Y283D^ ([Figure 4E](#fig4){ref-type="fig"}). In contrast, TF^mon^ slightly accelerated folding ([Figure 4E](#fig4){ref-type="fig"}). Because refolding of MBP^Y283D^ was performed in a chloride-free buffer in which MBP does not aggregate ([@bib2]), any contribution of an anti-aggregation effect can be excluded. Taken together, all assays showed that the monomeric and dimeric TF states have distinct chaperone activities.

TF dimerization accelerates its association rate with substrates. To understand how the oligomeric state of TF affects chaperone activity, we sought to determine how the monomeric and dimeric TF species interact with protein substrates. ITC showed that TF^mon^ has a 5-fold higher affinity (*K*~d~ \~ 6 μM) for protein substrates than the dimeric TF (*K*~d~ \~ 35 μM) ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). This is expected given that a sizable fraction of the substrate-binding surface is buried in the dimeric TF ([Figure 3B](#fig3){ref-type="fig"} and [Figure 5---figure supplement 2A](#fig5s2){ref-type="fig"}). Next, we measured the kinetics of substrate binding to TF using stopped-flow fluorescence spectroscopy. Notably, the rates of protein substrate association and dissociation are very different for the dimeric ([Figure 5A--C](#fig5){ref-type="fig"}) and monomeric TF ([Figure 5D and E](#fig5){ref-type="fig"}). Specifically, unfolded PhoA binds TF^mon^ with a *k*~on~ \~ 0.5 × 10^6^ M^−1^ s^−1^ and dissociates with a *k*~off~ \~ 6 s^−1^. In comparison, dimeric TF binds PhoA with a 2-fold faster association rate (*k*~on~ \~ 1.1 × 10^6^ M^−1^ s^−1^) and dissociates with a 5-fold faster dissociation rate (*k*~off~ \~ 30 s^−1^). The faster association of non-native proteins with the dimeric TF over the monomeric TF is consistent with the stronger holdase activity of dimeric TF ([Figure 4E](#fig4){ref-type="fig"}). Note that the holdase activity of a chaperone is determined by the difference between the folding rate of the substrate protein and the association rate between the chaperone and the unfolded substrate protein, as shown by kinetic experiments on SecB and TF ([@bib22]). Thus the association rate of dimeric TF for the substrate appears to be fast enough to delay the folding of the slowly folding mutant MBP^Y283D^, but not fast enough to delay the folding of wild type MBP ([Figure 4C and E](#fig4){ref-type="fig"}). Although three out of the five substrate-binding sites are partially occluded in the dimeric TF, assembly of the dimer brings next to each other substrate-binding sites A, B, and D in the two subunits. The sites are located within a large cavity that is accessible to unfolded proteins ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}) and present to the substrate a large contiguous binding surface that may account for the enhanced association rates of substrates with the dimeric TF.

![Effect of TF dimerization on binding kinetics.\
(**A**) Association of unfolded PhoA with TF monitored by tryptophan fluorescence. (**B**) Fitting of the data for the association of PhoA with TF by a single exponential function (gray line) or the sum of two exponential functions (black line), indicating that two exponential functions are required to fit the data. (**C**) Plots of the observed rate constant (*k*obs) as a function of the concentration of the dimer (left) and the monomer (right) of TF. (**D**) Association of PhoA with TFmon monitored by tryptophan fluorescence. (**E**) Plot of the observed rate constant (*k*obs) as a function of the concentration of monomeric TF.](elife-35731-fig5){#fig5}

Discussion {#s3}
==========

Our findings demonstrate how changes in the oligomerization state of a molecular chaperone may modulate the folding properties to interacting substrate proteins. The structural, energetic and kinetic data presented here explain previous observations and offer new insights into the various roles of TF in the cytoplasm ([Figure 6](#fig6){ref-type="fig"}). When bound to the ribosome ([Figure 6](#fig6){ref-type="fig"}, panel i), TF is in the monomeric form and exposes all substrate-binding sites to the nascent protein. The co-localization with the nascent chain results in TF delaying folding and preventing aggregation as shown before ([@bib1]; [@bib19]; [@bib36]; [@bib45]). As the nascent chain grows, additional TF molecules are recruited ([Figure 6](#fig6){ref-type="fig"}, panel ii) ([@bib24]). Because of the high concentration of free TF in the cytoplasm, it is likely that a TF molecule outcompetes and displaces the fraction of the nascent chain that is bound to the TF to form a TF dimer. In this case, folding of a domain may occur co-translationally ([Figure 6](#fig6){ref-type="fig"}, panel iii). Most cytosolic proteins released from the ribosome ([Figure 6](#fig6){ref-type="fig"}, panel iv) spontaneously form their native structure ([@bib3]) ([Figure 6](#fig6){ref-type="fig"}, panel v). However, in the absence of molecular chaperones, many proteins have a tendency to aggregate ([Figure 6](#fig6){ref-type="fig"}, panel vi). TF has an anti-aggregation activity, with the dimeric form being more potent than the monomeric form ([Figure 4A and C](#fig4){ref-type="fig"}). We posit that this is because of the higher local concentration of TF subunits in the dimeric form, which can both bind upon dimer dissociation with the interacting non-native polypeptide to protect longer segments of the polypeptide ([Figure 6](#fig6){ref-type="fig"}, panel vii). The increased local concentration of TF subunits results in faster association of the second molecule of TF to the substrate protein, which enables TF to more efficiently capture the substrate protein before the it starts to aggregate. This hypothesis is consistent with the following findings: (i) higher concentrations of monomeric TF are needed to achieve the same anti-aggregation activity as the dimeric TF ([Figure 4C](#fig4){ref-type="fig"}); and (ii) aggregation of shorter substrates, which are expected to bind to a single TF molecule, are equally prevented by the monomeric and dimeric TF ([Figure 4B](#fig4){ref-type="fig"}). Depending on the energetics and kinetics of interaction between TF and the non-native polypeptide in the cytoplasm, dimeric TF can also function as a potent holdase chaperone ([Figure 4E](#fig4){ref-type="fig"}) to delay the folding of proteins destined for export, such as periplasmic and outer membrane proteins ([@bib37]). Our findings demonstrate how the activity of a chaperone can be modulated and tailored to specialized needs in the cell simply by a change in the oligomeric state of the chaperone, without the need of ATP binding and hydrolysis cycles or the binding of co-factors.

![Chaperone activities of TF in the cell.\
The ribosome is shown in light blue. The protein substrate is shown in orange, and TF is represented as spheres with the subunits colored as in [Figure 2A](#fig2){ref-type="fig"}. See text for details.](elife-35731-fig6){#fig6}

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\                 Designation   Source or reference        Identifiers
  or resource                                                                      
  --------------------------------------- ------------- -------------------------- --------------------------------------------------------------
  Strain, strain background (*E. coli*)   BL21 (DE3)    NIPPON GENE CO., LTD.      ECOS Competent E. coli BL21 (DE3)

  Recombinant DNA reagent                 PhoA          [@bib45],PMID: 24812405    NCBIGene:945041

  Recombinant DNA reagent                 OmpA          [@bib50],PMID: 29606594    NCBIGene:945571

  Recombinant DNA reagent                 RT            [@bib23],PMID: 10531319    UniProtKB: P23070

  Recombinant DNA reagent                 MBP           [@bib22], PMID: 27501151   NCBIGene: 948538

  Recombinant DNA reagent                 TF            Takara Bio inc.            pCold-TF (TKR 3365)

  S7                                      S7            GenScript                  Gene synthesis

  Peptide, recombinant protein            GAPDH         Sigma-Aldrich              G-2267

  Software, algorithm                     CYANA3.97     [@bib14],PMID: 15318003    RRID:[SCR_014229](https://scicrunch.org/resolver/SCR_014229)

  Software, algorithm                     CNS           [@bib6], PMID: 18007608    RRID:[SCR_014223](https://scicrunch.org/resolver/SCR_014223)
  -----------------------------------------------------------------------------------------------------------------------------------------------

Sample preparation {#s4-1}
------------------

The *E. coli* TF, RBD (residues 1 to 117), PPD (residues 148 to 249), SBD (residues 113--432Δ150--246), TF^ΔRBD^ (residues 113 to 246), TF^ΔPPD^ (residues 1--432Δ150--243), OmpA^1-192^, and PhoA were expressed and purified as described previously ([@bib45]). TF, PPD, TF^ΔRBD^, and TF^ΔPPD^ were cloned into the pCold vector (Takara Bio). RBD and SBD were cloned into pET16b vector (Novagen) and fused to His~6~-MBP and a tobacco etch virus (TEV) protease cleavage site. TF mutants were constructed by site-directed mutagenesis using PfuTurbo High Fidelity DNA polymerase (Agilent) as well as PrimeSTAR Max (Takara Bio). OmpA^1-192^ was fused with N-terminal His~6~-tag and cloned into pET16b. Precursor form of maltose-binding protein (preMBP) and MBP^Y283D^ were expressed and purified as described previously ([@bib22]). *E. coli* reverse transcriptase (RT)-Ec86 255--320 was cloned into pCold-TF (Takara Bio) including a \~ 25 a.a. linker between TF and RT. *E. coli* S7 was cloned into pET16b vector and fused to His~6~-MBP, including a tobacco etch virus (TEV) protease cleavage site. All constructs were transformed into *E. coli* BL21 (DE3) cells.

For the unlabeled protein samples, cells were grown in Luria-Bertani (LB) medium at 37°C in the presence of ampicillin (100 mg L^−1^). Protein expression was induced by the addition of 0.2 to 0.5 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG) at OD~600~ \~ 0.6, followed by \~16 hr of incubation at 18°C. For isotopically labeled samples for NMR studies, cells were grown in minimal (M9) medium at 37°C in the presence of ampicillin (100 mg L^−1^). Protein expression was induced by the addition of 0.2 to 0.5 mM IPTG at OD~600~ \~ 0.6, followed by \~16 hr of incubation at 18°C. The samples with ^1^H,^13^C-labeled methyl and aromatic side chains in deuterium background were prepared as described previously ([@bib45]). The cells were grown in medium with ^15^NH~4~Cl (1 gL^−1^) and ^2^H~7~-glucose (2 gL^−1^) in 99.9% ^2^H~2~O (CIL and Isotec). For preparation of ^1^H-^13^C methyl-labeled samples, α-ketobutyric acid (50 mg L^−1^) and α-ketoisovaleric acid (85 mg L^−1^), \[^13^CH~3~\] methionine (50 mg L^−1^), \[^2^H~2~, ^13^CH~3~\] alanine (50 mg L^−1^) were added to the culture 1 hr before the addition of IPTG. For Phe and Tyr labeling, U-\[^1^H, ^13^C\]-labeled amino acids were added to the culture 1 hr before the addition of IPTG.

Cells were harvested and resuspended in the lysis buffer containing 50 mM Tris-HCl pH 8.0, 500 mM NaCl. Cells were disrupted by a high-pressure homogenizer or sonicator and centrifuged at 50,000 g for 45 min. TF, TF variants, and PhoA fragments were purified using Ni Sepharose 6 Fast Flow resin (GE Healthcare). In the case of RBD, SBD, and PhoA fragments that contain TEV cleavage site, the His~6~-MBP tag was removed by TEV protease at 4°C (incubation for 16 hr). The proteins were further purified by gel filtration using Superdex 75 16/60 or 200 16/60 columns (GE Healthcare). TF-RT complex was purified using Ni Sepharose 6 Fast Flow resin, followed by gel filtration using Superdex 200 16/60 column equilibrated with a solution containing 20 mM potassium phosphate (pH 7.0), 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, 0.05% NaN~3~. S7 was purified using Ni Sepharose 6 Fast Flow resin, followed by the removal of His~6~-MBP tag by TEV protease digestion at 4°C in the presence of TF. TF-S7 complex was further purified by gel filtration using Superdex 200 16/60 column equilibrated with a solution containing 20 mM potassium phosphate (pH 7.0), 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, 0.05% NaN~3~. MBP^Y283D^ and preMBP was purified using Ni Sepharose 6 Fast Flow resin, followed by gel filtration using Superdex 200 16/60 column equilibrated with a solution containing 100 mM HEPES, pH 7.5, 20 mM potassium acetate, 5 mM magnesium acetate. For OmpA^1-192^, the cell pellet was resuspended in a solution containing 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, and 8 M urea and incubated for 1 hr at room temperature, followed by centrifugation at 50,000 g for 45 min. The solubilized protein was purified using Ni Sepharose 6 Fast Flow resin, and eluted with a solution containing 50 mM Tris-HCl (pH 8.0), 500 mM NaCl, 400 mM imidazole, and 8 M urea.

NMR spectroscopy {#s4-2}
----------------

For NMR titrations and NOE measurement, NMR samples were prepared in 20 mM potassium phosphate (pH 7.0), 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, 0.05% NaN~3~, and 7% ^2^H~2~O. The proteins were concentrated to 0.3 \~ 2.2 mM for NOESY measurements. NMR spectra were recorded on Agilent UNITY Inova 600 and 800 MHz NMR spectrometers and Bruker Avance III 600, 700, and 800 MHz NMR spectrometers. Bruker Avance III 700 was equipped with cryogenic probe. The experiments were run at 10, 22, and 35°C. Spectra were processed using the NMRPipe program ([@bib11]), and data analysis was performed with Olivia (fermi.pharm.hokudai.ac.jp/olivia). NOE distance restraints for the dimer was collected by ^13^C-edited NOESY-HMQC, 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC, 3D-SOFAST-(^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC and ^13^C-edited SOFAST-NOESY-HMQC ([@bib42]) recorded on \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~; Phe-^13^C^15^N; Tyr-^13^C^15^N\]-labeled TF or on 1:1 mixture of \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~\]-labeled TF and \[Leu/Val-^13^CH~3~/^13^CH~3~; Phe-^13^C^15^N; Tyr-^13^C^15^N\]-labeled TF. The 1:1 mixture of the TF proteins with different labeling schemes enabled us to unambiguously identify the intermolecular NOEs: For example, an NOE observed between Ile and Leu can be unambiguously classified as an intermolecular NOE. Although the resonances from the interface, especially from RBD, undergo severe line broadening, high sensitivity of methyl resonances in deuterated background as well as high solubility and stability of TF at wide range of temperature enabled observation of substantial number of NOEs. NOEs were further collected by 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC, 3D-SOFAST-(^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC, and ^13^C-edited SOFAST-NOESY-HMQC recorded on \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~; Phe-^13^C^15^N; Tyr-^13^C^15^N\]-labeled RBD in complex with \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~\]-labeled TF^ΔRBD^. To corroborate intra-molecular distance restraints, 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC, 3D (^1^H)-^15^N HMQC-NOESY-^1^H-^13^C HMQC, 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^15^N HMQC, ^13^C-edited NOESY-HMQC, ^13^C-edited NOESY-HSQC, ^13^C-edited HSQC-NOESY, ^15^N-edited NOESY-HMQC, and ^15^N-edited NOESY-HSQC were recorded on \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~; Phe-^13^C^15^N; Tyr-^13^C^15^N\]-labeled RBD, \[U-^2^H; Ala-^13^CH~3~; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~; Phe-^13^C^15^N; Tyr-^13^C^15^N\]-labeled SBD, or ^13^C^15^N-labeled PPD.

Paramagnetic Relaxation Enhancement experiment {#s4-3}
----------------------------------------------

To observe paramagnetic relaxation enhancement (PRE), nitroxide spin label 1-oxyl-2,2,5,5-tetramethyl-3-pyrroline-3-methyl)-ethanethiosulfonate (MTSL, Toronto Research Chemicals Inc.) were introduced via cysteine-specific modification of TF K46C. Wild type TF has no cysteine residues. K46 mutant and its MTSL derivatives were determined not to perturb the TF structure, as assessed by ^1^H-^13^C HMQC spectra. After purification, \[U-^2^H; Met-^13^CH~3~; Ile-δ1-^13^CH~3~; Leu/Val-^13^CH~3~/^13^CH~3~\]-labeled TF K46C was exchanged into tris buffer (50 mM Tris-HCl pH 7.0, 50 mM KCl, and 1 mM β-mercaptoethanol). β-mercaptoethanol was removed by Zeba spin desalting column (Thermo Scientific, Waltham, MA) according to the manufacturer\'s protocol. MTSL was added from a concentrated stock in acetonitrile at a 10-fold excess, and the reaction was allowed to proceed at 4°C for \~12 hr. Excess MTSL was extensively removed by an Amicon stirred cell. PREs were observed from ^1^H-^13^C HMQC spectra of TF in the absence and presence of PhoA by measuring peak intensities before (paramagnetic) and after (diamagnetic) reduction of the nitroxide spin label with ascorbic acid.

Structure determination of TF dimer {#s4-4}
-----------------------------------

The resonances of the full-length dimeric TF (\~100 kDa) were assigned by a domain-parsing approach as reported previously ([@bib45]). Near-complete assignment of TF was achieved for the resonances from methyl side chain, aromatic side chain, and amide group. The structure of TF dimer was calculated by CYANA 3.97 ([@bib14]) using the NOE-derived distance restraints, dihedral angle-restraints, and hydrogen bond restraints. PREs were solely used to monitor TF monomerization upon the addition of the substrate protein ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}), and were not used in the structure calculation. NOE peak lists were obtained from 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC, 3D (^1^H)-^15^N HMQC-NOESY-^1^H-^13^C HMQC, 3D (^1^H)-^13^C HMQC-NOESY-^1^H-^15^N HMQC, 3D-SOFAST-(^1^H)-^13^C HMQC-NOESY-^1^H-^13^C HMQC and ^13^C-edited SOFAST-NOESY-HMQC, ^13^C-edited NOESY-HMQC, ^13^C-edited NOESY-HSQC, ^13^C-edited HSQC-NOESY, ^15^N-edited NOESY-HMQC, and ^15^N-edited NOESY-HSQC. Substantial number of inter- and intra-molecular NOEs were observed from NOESY spectra recorded on full length TF. The NOE restraints were further corroborated by the NOEs observed from isolated RBD in complex with TF^ΔRBD^. The chemical shift perturbation profiles as well as NOEs observed for RBD-TF^ΔRBD^ complex were consistent with those observed for full length TF, supporting the idea that the binding mode in the TF dimer is preserved in the interaction between the isolated domains. The intramolecular restraints obtained from NOESY experiments on full length TF were also corroborated by NOEs observed from the isolated domains of PPD, SBD and RBD. Note that most of the intramolecular NOEs from the isolated domains were consistent with the NOEs observed from TF dimer. A few intra-molecular NOEs observed from the isolated domains especially from the regions close to the dimer interface and the hinge regions were excluded in the calculation. Accordingly more than 2500 intramolecular NOEs as well as 54 intermolecular NOEs were collected for structure calculation ([Table 1](#table1){ref-type="table"}) ([Figure 2---figure supplement 4](#fig2s4){ref-type="fig"}). NOE restraints were corroborated by dihedral angle restraints derived from TALOS+ ([@bib47]) and hydrogen bond restraints added for the regions forming secondary structures as judged by the NOEs and TALOS+-derived dihedral angles. Intermolecular hydrogen bond restraints were added for the pair of atoms located close in the majority of the conformers in the NOE-derived preliminary structure. For the core region of RBD remote to the dimer interface, distance restraints from the crystal structure ([@bib13]) were loosely added to maintain overall fold of RBD. The 20 lowest-energy structures resulted from CYANA calculation were refined by restrained molecular dynamics in explicit water with CNS ([@bib6]). All of the intermolecular NOEs were well satisfied in the structure. The coordinates, restraints, chemical shift assignments have been deposited to PDB and BMRB.

SEC-MALS experiments {#s4-5}
--------------------

Size-exclusion chromatography with multi-angle light scattering (SEC-MALS) was measured using DAWN HELEOS-II (Wyatt Technology Corporation) downstream of a Shimadzu liquid chromatography system connected to Superdex 200 10/300 GL (GE Healthcare) gel filtration column, or using DAWN HELEOS8+ (Wyatt Technology Corporation) downstream of TOSOH liquid chromatography system connected to TSKgel G3000SWXL (TOSOH Corporation) gel filtration column. In both instruments, the differential refractive index (Shimadzu Corporation) downstream of MALS was used to obtain protein concentration. The running buffer was 20 mM potassium phosphate (pH 7.0), 100 mM KCl, 4 mM β-mercaptoethanol, and 0.5 mM EDTA. 100 \~ 200 µL of the sample was injected with a flow rate of 0.5 \~ 1.0 mL min^−1^. The data were analyzed with ASTRA version 6.0.5 or 7.0.1 (Wyatt Technology Corporation). To obtain the dissociation constant (*K*~d~) of TF dimer, TF was injected at varying concentrations, followed by *K*~d~ estimation based on the weight-averaged molar mass as determined by SEC-MALS and protein concentration at the peak top, using the following equation.$$M_{w} = M_{m}\left( \frac{8\lbrack M\rbrack_{T} + k_{d} - \sqrt{k_{d}^{2} + 8\lbrack M\rbrack_{T}k_{d}}}{4\lbrack M\rbrack_{T}} \right)$$

 where *M*w is the weight average molar mass obtained by SEC-MALS, \[*M*\]~T~ is the molar concentration of protein (as measured by change in refractive index), and *M*~m~ is molecular mass of the monomer. Nonlinear least square fitting was performed using Prism 5 (GraphPad Software).

Analytical ultracentrifugation experiments {#s4-6}
------------------------------------------

Sedimentation velocity experiments were conducted in a ProteomeLab XL-I analytical ultracentrifuge (Beckman Coulter, Indianapolis, IN) following standard protocols unless mentioned otherwise ([@bib4]). The samples, dialyzed overnight against the reference buffer (50 mM sodium phosphate pH 7.0, 100 mM NaCl) were loaded into a cell assembly comprised of a double sector charcoal-filled centerpiece with a 12 mm path length and sapphire windows. Buffer density and viscosity were determined in a DMA 5000 M density meter and an AMVn automated micro-viscometer (both Anton Paar, Graz, Austria), respectively. The partial specific volumes and the molecular masses of the proteins were calculated based on their amino acid compositions in SEDFIT (<https://sedfitsedphat.nibib.nih.gov/software/default.aspx>). The cell assembly, containing identical sample and reference buffer volumes of 360 µL, was placed in a rotor and temperature equilibrated at rest at 20°C for 2 hr before it was accelerated from 0 to 50,000 rpm. Absorbance scans at 230 and 280 nm were collected continuously for 12 hr. The velocity data were modeled with diffusion-deconvoluted sedimentation coefficient distributions c(s) in SEDFIT (<https://sedfitsedphat.nibib.nih.gov/software/default.aspx>), using algebraic noise decomposition and with signal-average frictional ratio and meniscus position refined with non-linear regression. The s-values were corrected for time and finite acceleration of the rotor was accounted for in the evaluation of Lamm equation solutions ([@bib4]). Maximum entropy regularization was applied at a confidence level of P-0.68.

Sedimentation velocity isotherm data that is the signal-weighted average sedimentation coefficients, sw(c), of the total sedimenting system derived from integration of the complete c(s) distributions at various concentrations (40.18, 12.13, 3.83 and 0.596 µM) of TF were fitted to a monomer-dimer self-association model using SEDPHAT (<https://sedfitsedphat.nibib.nih.gov/software/default.aspx>). For interacting systems, sw represents the average sedimentation property of the species under investigation. The association scheme used in this analysis was A + A ↔ A2 with equilibrium dissociation constant *K*~d~. All plots were generated with the program GUSSI (kindly provided by Dr. Chad Brautigam).

Stopped-flow experiments {#s4-7}
------------------------

Kinetic measurements were performed on FP-8300 Fluorescence Stopped Flow System (JASCO Corporation). The excitation and emission wavelengths were set at 280 nm (band width 10 nm) and 350 nm (band width 20 nm), respectively, so that the intrinsic tryptophan-fluorescence of PhoA^220-310^ containing two Trp residues or that of TF containing one tryptophan residue can be monitored. All measurements were carried out in the buffer containing 20 mM potassium phosphate (pH 7.0), 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, 0.05% NaN~3~. Individual kinetics were typically measured 40 times and averaged. The data were analyzed with Prism 5 (GraphPad Software). To account for photobleaching, an exponential baseline was defined using the data after 1000 ms of the mixing, by which the dissociation or association has completed and reached to the equilibrium. Dissociation of TF dimer was initiated by 10-fold dilution of TF at 1 µM. The temperature was set to 22°C. The protein solution was placed in 2.5 mL syringe and the buffer was placed in 10 mL syringe. The dissociation kinetics was analyzed using a single exponential function. Binding between TF and PhoA^220-310^ was monitored after rapid mixing by the stopped-flow instrument. Association of PhoA^220-310^ and TF or TF^mon^ was initiated by mixing equal volumes of 4 µM PhoA220-310 and 0--80 µM TF or TF^mon^ resulting in final concentrations of 2 µM PhoA^220-310^ and 0--40 µM TF or TF^mon^. A single tryptophan residue in TF (W151) was mutated to phenylalanine in order to selectively monitor the change in the fluorescence from PhoA^220-310^ containing two residues both located in the binding sites for TF ([@bib45]). Both samples were placed in the 10 mL syringe. The temperature was set to 18°C. The fluorescence intensity of PhoA^220-310^ increased upon binding to TF as seen in the previous report using reduced and carboxymethylated form of α-lactalbumin (RCM-La). When PhoA^220-310^ was mixed with the monomeric mutant TF^mon^, each of the time traces was well explained by a single exponential curve. The time traces at varying concentration of TF^mon^ showed linear dependence of the observed rate *k*~obs~ on the concentration of TF^mon^, and *k*~on~ and *k*~off~ were extracted by fit of the data to the linear function of *k*~obs~ = *k*~on~\[TF\]+*k*~off~. On the other hand, the time traces of the binding between PhoA^220-310^ and TF were best represented as the sum of the two exponential curves. The fit of the time traces to two exponential functions resulted the fraction of the fast phase more than 80% that increased as the concentration of TF increased. The fraction for the fast phase coincides with the fraction of the dimer as estimated by the *K*~d~ of dimerization (2 µM) determined by the AUC experiment, and thus we concluded that the fast and slow phases are attributed to the binding of PhoA^220-310^ to the dimer and the monomer fractions of TF, respectively. The concentration for the plots of *k*~obs~ was calculated for each of the dimer and the monomer, using the *K*~d~ of dimerization (2 µM). The kinetic parameters determined for the monomer fraction of TF roughly correspond to those determined for the monomeric mutant TF^mon^.

ITC experiments {#s4-8}
---------------

For the ribosome and TF, calorimetric titrations were carried out on iTC200 microcalorimeter (GE healthcare) at 22°C. All protein samples were dialyzed against ITC buffer containing 20 mM HEPES, pH 7.5, 50 mM potassium acetate, 20 mM MgCl~2~, and 1 mM tris(2-carboxyethyl)phosphine (TCEP). The 200 µL sample cell was filled with 12 µM solution of the ribosome, and 40 µL injection syringe was filled with 160 to 190 µM solution of TF or RBD. The titrations were carried out with a preliminary 0.2 µL injection, followed by 14 injections of 2.5 µL each with time intervals of 5 min. The solution was stirred at 1000 rpm. For unfolded substrates (PhoA^220-310^ or MBP^198-265^) and TF, TF^mon^, or TF^ΔRBD^, calorimetric titrations were carried out on Auto-iTC200 microcalorimeter (GE healthcare). The calorimetric titrations for PhoA220-310 and MBP198-265 were performed at 8°C and 22°C, respectively. All protein samples were purified in ITC buffer containing 20 mM potassium phosphate (pH 7.0), 100 mM KCl by gel filtration. For titration of PhoA^220-310^, the 200 µL sample cell was filled with 90 µM solution of TF, TF^mon^, or TF^ΔRBD^, and 40 µL injection syringe was filled with 1.1 mM solution of PhoA^220-310^. For titration of MBP^198-265^, the 200 µL sample cell was filled with 110 µM solution of TF or TF^ΔRBD^, and 40 µL injection syringe was filled with 1.1 mM solution of MBP198-265. The titrations were carried out with a preliminary 0.2 µL injection, followed by 8 injections of 4.2 µL each with time intervals of 5 min. The solution was stirred at 1000 rpm. Data for the preliminary injection, which are affected by diffusion of the solution from and into the injection syringe during the initial equilibration period, were discarded. Binding isotherms were generated by plotting heats of reaction normalized by the modes of injectant versus the ratio of total injectant to total protein per injection. The data were fitted with Origin 7.0 (OriginLab Corporation, Northampton, MA).

Anti-aggregation assays {#s4-9}
-----------------------

Aggregation of denatured GAPDH from rabbit muscle (Sigma; G-2267) was measured as described previously ([@bib45]). 125 µM GAPDH was denatured by 3 M guanidine-HCl in 20 mM potassium phosphate, pH 7.0, 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, and 0.05% NaN~3~ for 12 hr at 4°C. The denatured GAPDH was diluted 50-fold into the buffer that does not contain guanidine-HCl and aggregation was monitored by 90° light scattering at 620 nm on a spectrofluorometer (FP-8500, JASCO Corporation) in the absence or presence of TF or TF^mon^ at the concentration of 0.5 µM or 1 µM. The experiment was carried out at 20°C. The reproducibility was confirmed by independent assays repeated three times.

In anti-aggregation assay on OmpA^1-192^, 62 µM OmpA^1-192^ in 50 mM Tris-HCl pH 8.0, 500 mM NaCl, 400 mM imidazole, and 8 M urea was diluted 20-fold into 20 mM potassium phosphate, pH 7.0, 100 mM KCl, 4 mM β-mercaptoethanol, 0.5 mM EDTA, and 0.05% NaN~3~. Aggregation was monitored by 90° light scattering at 620 nm on a spectrofluorometer (FP-8500, JASCO Corporation) in the absence or presence of TF or TF^mon^ at the concentration of 4 µM. The experiment was carried out at 25°C.

MBP refolding assay {#s4-10}
-------------------

Refolding experiments of the precursor form of MBP, preMBP, and slower folding mutant, MBP^Y283D^, were performed as described before ([@bib22]) with some modifications. The proteins were denatured in the buffer containing 100 mM HEPES, pH 7.5, 20 mM potassium acetate, 5 mM magnesium acetate, and 8 M urea. PreMBP and MBP^Y283D^ were concentrated to 80 and 32 µM, respectively. Refolding of preMBP was initiated by 20-fold rapid dilution into the buffer containing 50 mM sodium phosphate, pH 7.0, 150 mM NaCl, and 0.05% NaN~3~. Refolding process of preMBP in the absence and presence of TF or TF^ΔRBD^ at the concentration of 4 or 20 µM was monitored by an increase in tryptophan fluorescence intensity. Fluorescence intensity was measured using a microplate reader (Infinite 200 PRO, Tecan). The excitation and emission wavelengths were set at 295 nm (band width 5 nm) and 335 nm (band width 20 nm), respectively. The refolding was performed three times and averaged. All measurements were performed at 25°C. Data were analyzed by Prism 5 (GraphPad Software) using single exponential function. Refolding of MBP^Y283D^ was initiated by 20-fold rapid dilution into the buffer containing 100 mM HEPES, pH 7.5, 20 mM potassium acetate, 5 mM magnesium acetate and the refolding process of MBP^Y283D^ in the absence and presence of TF or TF^mon^ at the concentration of 10 or 20 µM was monitored by an increase in tryptophan fluorescence intensity. Fluorescence intensity was measured using a spectrofluorometer (FP-8500, JASCO Corporation). The excitation and emission wavelengths were set at 295 nm (band width 2.5 nm) and 335 nm (band width 5 nm), respectively. The refolding was performed three times and averaged. All measurements were performed at 25°C.
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Atomic coordinates for the TF dimer structure have been deposited in the Protein Data Bank (ID 6D6S).

The following dataset was generated:

Tomohide SaioSoichiro KawagoeKoichiro IshimoriCharalampos G Kalodimos2018Solution structure of Trigger Factor dimer<http://www.rcsb.org/pdb/search/structidSearch.do?structureId=> 6D6SPublicly available at the RCSB Protein Data Bank (accession no. 6D6S)
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Oligomerization of a molecular chaperone modulates its activity\" for consideration by *eLife*. Your article has been favorably evaluated by John Kuriyan (Senior Editor) and three reviewers, one of whom, Lewis E Kay (Reviewer \#1), is a member of our Board of Reviewing Editors.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Your work has been reviewed by three experts who are all very positive but suggest minor improvements for a subsequent revision. In particular, all reviewers noted that the structure of the TF dimer is a major accomplishment both technically and in terms of the information that it provides concerning mechanism of action. Indeed, reviewers write: \"This work makes important contributions to the chaperone biology by rationalizing observations in structural terms. Moreover, the structural studies of such a large complex are far from routine and the work thus serves as an excellent example of the power of modern NMR approaches. Overall this is an excellent paper\". \"This is a major contribution because:

\- TF is representative of ATP-independent chaperones, which are not as well understood as ATP-dependent chaperones, such as GroEL.

\- The authors were able to cleverly overcome major technical challenges posed by the high MW and the dynamic nature of the monomer/dimer exchange.

\- The monomer/dimer equilibrium is central to the chaperone function of TF, not only as a modulatory mechanism, but also because it is known that TF binds, as a monomer, at the ribosome to prevent the aggregation of nascent polypeptides, while it functions as a dimer in cytosol to assist protein folding and prevent aggregation of unfolded protein.

\- The structure informs a new molecular mechanism for the TF chaperone (Figure 5)\"

\"The widely accepted concept is that TF dimerization is a storage form of the chaperone. An alternative function of the TF dimer in binding folded, small substrates was suggested by the crystal structure of the Thermotoga maritima TF in complex with the ribosomal protein S7 (Martinez-Hackert and Hendrickson, 2009). Saio et al. elegantly rule out the second scenario, by showing that it is the monomeric TF that binds two S7 molecules and that the S7 protein is unfolded when bound.\"

We would encourage the authors to address point 6 below experimentally and perhaps aspects of point 1, but acceptance is not predicated on new experimental data.

Major:

1\) The authors utilize a mutant TF, ensuring that the kinetic parameters obtained refer to the monomeric form of the protein. But I wonder about the parameters for the dimer. Since substrate can bind to monomers with higher affinity than dimers (as the authors mention) and dimer dissociation is a route for substrate binding, are the measured on/off rates for dimer contaminated by the monomer-dimer equilibrium (even though the equilibrium amount of dimer is much higher than monomer)? Is it possible to prepare a disulfide-linked dimer that would provide a better mimic of the dimeric chaperone, without complications? The question is of interest as the authors argue that the better anti-aggregation activity of the dimer reflects in part the fact that the dimer can dissociate to form 2 monomers, which are then both available for binding. If the dimer could not dissociate into monomers then would the monomer TF be a more potent anti-aggregator or would the faster on rate for the dimer still play an effect? Given that the KDs for dimerization, and for substrate binding for both monomer and dimeric TF are available and assuming physiological concentrations of TF (50 μM) and of substrate it should be possible to calculate the fraction of substrate that is bound to TF that is a monomer or a dimer.

2\) In Figure 3 the authors speak about a holdase activity for the dimeric TF form. They rationalize this in terms of the faster association rates measured. Yet, naïvely I would have thought that what is important for a holdase activity is the lifetime of the bound complex or 1/*k~off~*; and *k~off~*is much larger for the dimer than the monomeric TF. (ii) Why is there not a holdase effect on the WT MBP protein? (iii) I would imagine that for TF to prevent aggregation the substrate on rate must be greater than the aggregation rates. Can the authors compare their measured on rates to aggregations rates to verify this if aggregation rates are available?

3\) The spectrum of the dimeric TF shows significant broadening of residues from the RBD, seen both in cases of amide resonances (Morgado et al., 2017) and of methyl group selective labeling (Saio et al., 2014). A major concern is that the current structure does not explain that broadening, that most likely reports on a dynamic assembly. This then raises the question -- how well does this single conformation satisfy all the distance restraints?

Also, due to the broadening of the RBD residues, how many NOEs were reliably measured between the RBD and the other TF domain in the dimer? Also it is important that the chemical shifts are deposited in the BMRB, and that the scripts containing restraints used for structure calculations be including in supporting information.

4\) The observation that the wild type \"dimeric\" TF has better \"chaperone\" activity than the monomeric TF is a bit confusing. As TF monomerizes upon binding to substrate the overall aggregation activity should in principle be quite similar between the wild type and mutant TF.

5\) Another point is that the chaperone activities of wild type TF and TF^ΔRBD^ truncation that results in TF monomerization were found to be very similar (Merz et al., 2006). Perhaps the authors can also compare between wt ΔRBD monomer TF for their substrates

6\) Last point regarding the chaperone activity is that the prevention of GAPDH aggregation was done using 0.5μm of TF dimer which is significantly below the K~D~ for dimer formation. It would be beneficial to repeat the experiment using higher concentrations of TF (but same GAPDH: TF ratio) to see whether the effect is bigger for fully formed TF dimers.

10.7554/eLife.35731.026

Author response

> Major:
>
> 1\) The authors utilize a mutant TF, ensuring that the kinetic parameters obtained refer to the monomeric form of the protein. But I wonder about the parameters for the dimer. Since substrate can bind to monomers with higher affinity than dimers (as the authors mention) and dimer dissociation is a route for substrate binding, are the measured on/off rates for dimer contaminated by the monomer-dimer equilibrium (even though the equilibrium amount of dimer is much higher than monomer)? Is it possible to prepare a disulfide-linked dimer that would provide a better mimic of the dimeric chaperone, without complications? The question is of interest as the authors argue that the better anti-aggregation activity of the dimer reflects in part the fact that the dimer can dissociate to form 2 monomers, which are then both available for binding. If the dimer could not dissociate into monomers then would the monomer TF be a more potent anti-aggregator or would the faster on rate for the dimer still play an effect? Given that the KDs for dimerization, and for substrate binding for both monomer and dimeric TF are available and assuming physiological concentrations of TF (50 μM) and of substrate it should be possible to calculate the fraction of substrate that is bound to TF that is a monomer or a dimer.

We had previously tried to prepare a disulfide-linked TF dimer but unfortunately it proved not to be a good mimic of the physiological dimer (and thus we decided not to include the data in the original submission). We designed a mutant TF (I80C/E383C) in which the two surface amino acid residues located at the RBD-Arm2 interface in the dimer were mutated to Cys. Based on the structural data this pair was expected to form a favorable disulfide bond. SEC-MALS showed that the oxidized form of TF I80C/E383C mutant indeed forms a stable dimer, even at concentrations below the dimerization K~D~ of (\~2 μM). NMR spectra of the oxidized TF I80C/E383C showed that the chemical shift of most of the resonances matched those of wt TF. However, several resonances corresponding to residues located at the RBD-Arm2 interface were broadened in the spectrum of the mutant, which suggests that the S-S bridge may have destabilized the local structure around the substrate-binding site B and/or alter the dynamics of the dimeric interface. The stopped-flow experiments indeed showed that the association kinetics between the TF I80C/E383C mutant and protein substrate is much slower than that between wt TF and protein substrate. Because the substrate-binding site-B on TF partially overlaps with the dimer interface, these results imply that the introduction of the intermolecular disulfide bridge or cysteine mutations disturbs the substrate binding site on TF. Since all the dimer interfaces partially overlap with substrate-binding sites, it has been impossible to introduce a disulfide bridge without disrupting substrate binding to TF.

> 2\) In Figure 3 the authors speak about a holdase activity for the dimeric TF form. They rationalize this in terms of the faster association rates measured. Yet, naïvely I would have thought that what is important for a holdase activity is the lifetime of the bound complex or 1/k~off~; and k~off~ is much larger for the dimer than the monomeric TF. (ii) Why is there not a holdase effect on the WT MBP protein? (iii) I would imagine that for TF to prevent aggregation the substrate on rate must be greater than the aggregation rates. Can the authors compare their measured on rates to aggregations rates to verify this if aggregation rates are available?

As shown in our previous work by Huang et al., 2016, the kinetic competition between the substrate folding rate (*k*~fold~) and its association rate with the chaperone (*k~on~*) determines the effect of the chaperone on the folding of the substrate protein. Although *k~off~*may also play a role, it is in this case of almost no relevance given that the dissociation rates between chaperones and substrates are relatively fast. Whether a chaperone delays the folding of a substrate is determined by how quickly it can associate with the unfolded state of the substrate before it has the chance to fold to its native state. We added relevant text elaborating this point in the eighth paragraph of the Results.

ii\) The reason is that wt MBP has a fast folding rate and thus TF has no effect. Even strong holdase chaperones such as SecB have little effect on the folding rate of wt MBP. More details and kinetic rates are provided in our previous work (Huang et al., 2016).

\(iii\) Assuming that the binding kinetics for the unfolded GAPDH is similar to that for the unfolded PhoA, the association rate between TF and GAPDH is expected to be \~0.5 s^-1^, which is indeed much faster than the process of overall aggregation (Figure 4A). There are no rates for the individual processes leading to aggregation and thus a direct comparison is currently not possible.

> 3\) The spectrum of the dimeric TF shows significant broadening of residues from the RBD, seen both in cases of amide resonances (Morgado et al., 2017) and of methyl group selective labeling (Saio et al., 2014). A major concern is that the current structure does not explain that broadening, that most likely reports on a dynamic assembly. This then raises the question -- how well does this single conformation satisfy all the distance restraints?
>
> Also, due to the broadening of the RBD residues, how many NOEs were reliably measured between the RBD and the other TF domain in the dimer? Also it is important that the chemical shifts are deposited in the BMRB, and that the scripts containing restraints used for structure calculations be including in supporting information.

The measured kinetics of TF dimer association and dissociation suggest that the broadening of resonances corresponding to residues located at the dimeric interface is due to the monomer-dimer transition, rather than internal dynamics within TF. This is further corroborated by the observation that the methyl TROSY spectra of dimeric TF at higher concentrations exhibit reduced line broadening. The spectra reported in the current work are of much higher quality than the ones reported in Saio et al., 2014 as a result of optimized experimental conditions (Figure 2---figure supplement 1). We have added a in the subsection "Structure of dimeric TF". All of the intermolecular NOEs are well satisfied in the structure as shown in [Author response image 1](#respfig1){ref-type="fig"}, indicating that the dimeric TF structure is faithfully represented by our NOE-derived distance restraints. All of the coordinates, restraints, chemical shift assignments are being deposited to PDB and BMRB. We have added relevant text to the subsection "Structure determination of TF dimer".

![NOE mapping for the interfaces for PPD-RBD and Arm1-RBD (left panel) and Arm2-RBD.\
The intermolecular NOEs are indicated by red lines. TF domains are colored as in Figure 2.](elife-35731-resp-fig1){#respfig1}

> 4\) The observation that the wild type \"dimeric\" TF has better \"chaperone\" activity than the monomeric TF is a bit confusing. As TF monomerizes upon binding to substrate the overall aggregation activity should in principle be quite similar between the wild type and mutant TF.

We propose here that the difference in the chaperone activities between the dimeric TF and the monomeric TF is due to the differences in the binding kinetics to the substrate protein and the local concentration. Especially for anti-aggregation activity, the elevated local concentration of TF by dimerization is a major factor as explained in the Discussion. The binding to the substrate leads to the dissociation of the dimer into monomers as shown by SEC-MALS (Figure 1---figure supplement 1E) and NMR (Figure 1---figure supplement 1A). Upon dissociation, one dimer generates two monomeric TF that both co-localize nearby the substrate protein. For a long substrate protein consisting of \> \~200 amino acid residues such as GAPDH (\~350 a.a.) and MBP (\~400 a.a.), both of TF monomers are used to capture the substrate protein (Figure 6, panels vii and viii). Thus, the dissociation of TF dimer into monomers upon binding to the substrate protein results in higher local concentration of TF around the substrate protein, resulting in faster association of the second TF molecule to the substrate protein. The faster association enables TF to more efficiently capture the substrate protein before the substrate proteins aggregate. Such an effect is not observed when a shorter substrate is used, in which case only one TF molecule is sufficient to bind the entire substrate. We have added relevant text to the Discussion.

> 5\) Another point is that the chaperone activities of wild type TF and TF^ΔRBD^ truncation that results in TF monomerization were found to be very similar (Merz et al., 2006). Perhaps the authors can also compare between wt ΔRBD monomer TF for their substrates

Merz et al. tested several TF variants including TF wt and TF^ΔRBD^ and showed the decreased anti-aggregation activity as well as decreased holdase activity for TF^ΔRBD^. These observations are consistent with our results. In our GAPDH aggregation assay, as well as MBP refolding assay, the effect of TF^ΔRBD^ was also assessed and the results showed that the activity of TF^ΔRBD^ was essentially the same as that of the TF monomeric mutant. We added relevant text about TF^ΔRBD^ and cited the paper in the first paragraph of the subsection "Dimerization modulates the chaperone activities of TF".

> 6\) Last point regarding the chaperone activity is that the prevention of GAPDH aggregation was done using 0.5 μm of TF dimer, which is significantly below the K~D~ for dimer formation. It would be beneficial to repeat the experiment using higher concentrations of TF (but same GAPDH: TF ratio) to see whether the effect is bigger for fully formed TF dimers.

We also performed GAPDH aggregation assay in the presence of TF variants at higher concentrations. At TF concentration of 1 μM, the monomeric mutant (TF^mon^) exhibited weaker anti-aggregation activity than wt TF, which is consistent with the result in the presence of 0.5 μM of TF and TF^mon^. However, the difference between dimeric TF and monomeric TF is smaller at 1 μM concentration because at this higher concentration even the monomeric TF can efficiently suppress aggregation. We have added a new figure (Figure 4---figure supplement 1). We did not increase the concentration of GAPDH because the aggregation is very sensitive to the experimental conditions including concentration of protein and denaturant, dilution factor, and temperature, and thus change of GAPDH concentration would require extensive optimization. Almost all previous GAPDH aggregation assays have been performed using the similar conditions to the ones used in this work.
